Generation Bio Free Cash Flow 2020-2023 | GBIO
Generation Bio free cash flow from 2020 to 2023. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Generation Bio Annual Free Cash Flow |
| 2023 |
-60.14 |
| 2022 |
-111.25 |
| 2021 |
-97.67 |
| 2020 |
-75.66 |
| 2019 |
-60.25 |
| Generation Bio Quarterly Free Cash Flow |
| 2023-12-31 |
-60.14 |
| 2023-09-30 |
-30.58 |
| 2023-06-30 |
-5.08 |
| 2023-03-31 |
-28.43 |
| 2022-12-31 |
-111.25 |
| 2022-09-30 |
-87.56 |
| 2022-06-30 |
-66.44 |
| 2022-03-31 |
-38.22 |
| 2021-12-31 |
-97.67 |
| 2021-09-30 |
-74.04 |
| 2021-06-30 |
-50.65 |
| 2021-03-31 |
-23.94 |
| 2020-12-31 |
-75.66 |
| 2020-09-30 |
-55.50 |
| 2020-06-30 |
-35.49 |
| 2020-03-31 |
-19.79 |
| 2019-12-31 |
|
| 2019-09-30 |
-47.37 |
| 2019-06-30 |
-29.96 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.193B |
$0.006B |
|
Generation Bio Co. is a genetic medicines company. It is focused on creating gene therapy for patients suffering from both rare and prevalent diseases. Generation Bio Co. is based in CAMBRIDGE, Mass.
|
